Cortical Vein Thrombosis after Infliximab Treatment for Crohn's Disease.

Saeed Razmeh, Nafiseh Niknam, Negar Sadat Rabbani, Shekoofeh Nikoee, Fatemeh Vafa Pour, Laleh Taghavian

Open access · goldAbstract readCase Reports

In one paragraph

Article in Neurology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 35% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

Central retinal vein occlusion after infliximab therapy in a young patient with ulcerative colitis.JPGN reports · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Saeed RazmehDepartment of Neurology, Shahid Beheshti Hospital, Yasuj University of Medical Sciences, Yasuj 75914-93686, Iran.

Nafiseh NiknamStudent Research Committee, Yasuj University of Medical Sciences, Yasuj 75914-93686, Iran.

Negar Sadat RabbaniStudent Research Committee, Yasuj University of Medical Sciences, Yasuj 75914-93686, Iran.

Shekoofeh NikoeeStudent Research Committee, Yasuj University of Medical Sciences, Yasuj 75914-93686, Iran.

Fatemeh Vafa PourDepartment of Internal Medicine, Emam Sajad Hospital, Yasuj University of Medical Sciences, Yasuj 75914-93686, Iran.

Laleh TaghavianNursing Department, Shahid Beheshti Hospital, Yasuj University of Medical Sciences, Yasuj 75914-93686, Iran.

Yasuj University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease puts patients at high risk of thromboembolism accidents. These patients may take infliximab for active and fistulating Crohn's disease, which can also increase the risk of thrombosis. Deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) are more common among these patients, but cerebrovascular, mesenteric, portal and retinal veins can also be affected. In this paper, we report a case of isolated right Labbe vein thrombosis after infliximab therapy for Crohn's disease. To the best of our knowledge, our patient is the first case report of isolated cortical vein thrombosis following administration of rituximab for Crohn's disease.

Indexed as

cortical vein thrombosisCrohn’s diseaseinfliximab

Identifiers

PMID33799515

DOI10.3390/neurolint13010011

PMCPMC8005946

OpenAlexW3136334284

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.